TRIPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TRIPHARMA
Largest movements
- Tangible fixed assets -€151,993
down €151,993 (-93.4%), from €162,698 to €10,706
of which Land and buildings: -€147,700
- Cash +€25,509
up €25,509 (+134.2%), from €19,004 to €44,513
mainly Investment in fixed assets (net) (+€145,529) and Net result for the year (+€68,582)
- Receivables within one year -€23,366
down €23,366 (-13.6%), from €171,845 to €148,480
of which Trade receivables: -€23,637
- Stocks and contracts +€8,777
up €8,777 (+16.9%), from €51,980 to €60,757
- Debts after one year -€99,627
down €99,627 (-100.0%), from €99,627 to €0
- Profit (loss) carried forward +€68,582
up €68,582 (+49.6%), from -€138,307 to -€69,725
- Trade debts -€60,253
down €60,253 (-37.0%), from €162,694 to €102,442
- Current portion of long-term debt -€21,491
down €21,491 (-100.0%), from €21,491 to €0
- Other debts -€18,734
down €18,734 (-9.4%), from €199,647 to €180,912
- Gross operating margin +€89,296
up €89,296 (+86.2%), from €103,611 to €192,907
- Other operating charges +€16,046
up €16,046 (+1705.7%), from €941 to €16,987
- Staff costs +€12,895
up €12,895 (+17.7%), from €72,805 to €85,700
- Depreciation -€11,550
down €11,550 (-64.1%), from €18,014 to €6,464
- Financial charges +€8,903
up €8,903 (+135.2%), from €6,584 to €15,487
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €407,146 | €266,344 | -€140,803 | -34.6% |
| Fixed assets | 21/28 | €163,106 | €11,113 | -€151,993 | -93.2% |
| Tangible fixed assets | 22/27 | €162,698 | €10,706 | -€151,993 | -93.4% |
| Land and buildings | 22 | €147,700 | €0 | -€147,700 | -100.0% |
| Plant, machinery and equipment | 23 | €5,272 | €9,297 | +€4,025 | +76.3% |
| Furniture and vehicles | 24 | €9,726 | €1,408 | -€8,318 | -85.5% |
| Financial fixed assets | 28 | €407 | €407 | = | 0.0% |
| Current assets | 29/58 | €244,041 | €255,231 | +€11,190 | +4.6% |
| Stocks and contracts in progress | 3 | €51,980 | €60,757 | +€8,777 | +16.9% |
| Stocks | 30/36 | €51,980 | €60,757 | +€8,777 | +16.9% |
| Amounts receivable within one year | 40/41 | €171,845 | €148,480 | -€23,366 | -13.6% |
| Trade receivables | 40 | €122,786 | €99,149 | -€23,637 | -19.3% |
| Other amounts receivable | 41 | €49,060 | €49,331 | +€271 | +0.6% |
| Cash at bank and in hand | 54/58 | €19,004 | €44,513 | +€25,509 | +134.2% |
| Deferred charges and accrued income | 490/1 | €1,211 | €1,481 | +€270 | +22.3% |
| Total equity and liabilities | 10/49 | €407,146 | €266,344 | -€140,803 | -34.6% |
| Equity | 10/15 | -€97,539 | -€28,957 | +€68,582 | +70.3% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €22,176 | €22,176 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Distributable reserves | 133 | €20,317 | €20,317 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€138,307 | -€69,725 | +€68,582 | +49.6% |
| Amounts payable | 17/49 | €504,685 | €295,300 | -€209,385 | -41.5% |
| Amounts payable after more than one year | 17 | €99,627 | €0 | -€99,627 | -100.0% |
| Financial debts | 170/4 | €99,627 | €0 | -€99,627 | -100.0% |
| Amounts payable within one year | 42/48 | €402,420 | €295,300 | -€107,119 | -26.6% |
| Current portion of amounts payable after more than one year | 42 | €21,491 | €0 | -€21,491 | -100.0% |
| Financial debts | 43 | €4,052 | €0 | -€4,052 | -100.0% |
| Credit institutions | 430/8 | €4,052 | €0 | -€4,052 | -100.0% |
| Trade debts | 44 | €162,694 | €102,442 | -€60,253 | -37.0% |
| Suppliers | 440/4 | €162,694 | €102,442 | -€60,253 | -37.0% |
| Taxes, remuneration and social security | 45 | €14,536 | €11,946 | -€2,590 | -17.8% |
| Taxes | 450/3 | €3,134 | €396 | -€2,738 | -87.4% |
| Remuneration and social security | 454/9 | €11,402 | €11,550 | +€148 | +1.3% |
| Other amounts payable | 47/48 | €199,647 | €180,912 | -€18,734 | -9.4% |
| Accrued charges and deferred income | 492/3 | €2,638 | €0 | -€2,638 | -100.0% |
| Remuneration, social security and pensions | 62 | €72,805 | €85,700 | +€12,895 | +17.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,014 | €6,464 | -€11,550 | -64.1% |
| Other operating charges | 640/8 | €941 | €16,987 | +€16,046 | +1705.7% |
| Gross operating margin | 9900 | €103,611 | €192,907 | +€89,296 | +86.2% |
| Operating profit (loss) | 9901 | €11,852 | €83,756 | +€71,904 | +606.7% |
| Financial income | 75/76B | €0 | €699 | +€699 | +367821.1% |
| Recurring financial income | 75 | €0 | €699 | +€699 | +367821.1% |
| Financial charges | 65/66B | €6,584 | €15,487 | +€8,903 | +135.2% |
| Recurring financial charges | 65 | €6,584 | €15,487 | +€8,903 | +135.2% |
| Profit (loss) for the period before taxes | 9903 | €5,268 | €68,968 | +€63,700 | +1209.2% |
| Income taxes | 67/77 | €469 | €385 | -€83 | -17.8% |
| Profit (loss) for the period | 9904 | €4,799 | €68,582 | +€63,783 | +1329.0% |
| Profit (loss) for the period to be appropriated | 9905 | €4,799 | €68,582 | +€63,783 | +1329.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.